« Previous | Contents | Next »
Listen
SCOTTISH CRIME SURVEY 2003
Table A.7.3. Percentage of female respondents reporting using drugs 'ever' and 'in the last year', 2003
| 16-19 | 20-24 | 25-29 | 30-34 | 35-39 | 40-59 | 16-59 |
EVER |
Any drug | 31.5 | 44.0 | 38.7 | 25.7 | 18.4 | 11.9 | 22.2 |
Amphetamines | 14.1 | 18.5 | 27.4 | 9.3 | 7.5 | 4.7 | 10.2 |
Cannabis | 29.9 | 41.3 | 33.9 | 19.9 | 17.2 | 8.6 | 18.9 |
Cocaine | 8.7 | 10.3 | 7.5 | 4.9 | 5.4 | 1.6 | 4.6 |
Crack | 5.5 | 3.8 | 2.2 | 2.2 | 1.7 | 1.4 | 2.2 |
Ecstasy | 17.3 | 14.7 | 14.5 | 7.1 | 5.0 | 1.4 | 6.6 |
Heroin | 7.1 | 3.3 | 1.6 | 1.3 | 2.1 | 1.1 | 2.0 |
Methadone | 5.5 | 2.7 | 1.6 | 1.3 | 2.1 | 1.4 | 1.9 |
LSD | 5.5 | 7.6 | 12.9 | 4.4 | 4.6 | 1.9 | 4.6 |
Magic mushrooms | 8.7 | 8.7 | 9.1 | 4.8 | 5.0 | 2.4 | 4.9 |
Temazepam | 5.5 | 3.8 | 5.9 | 4.9 | 3.3 | 2.4 | 3.6 |
Valium | 14.1 | 2.7 | 3.8 | 3.5 | 5.4 | 2.0 | 3.8 |
Glues | 7.1 | 4.3 | 3.2 | 3.1 | 2.1 | 1.3 | 2.6 |
Pills | 5.5 | 2.7 | 1.6 | 1.3 | 1.7 | 1.6 | 2.0 |
Anabolic steroids | 5.5 | 2.2 | 2.2 | 1.8 | 1.3 | 1.3 | 1.8 |
Poppers | 11.0 | 7.1 | 13.4 | 5.8 | 4.2 | 1.1 | 4.8 |
LAST YEAR |
Any drug | 19.7 | 25.0 | 10.2 | 5.8 | 2.5 | 2.4 | 7.3 |
Amphetamines | 3.9 | 3.3 | 2.7 | 0.4 | | 1.3 | 1.5 |
Cannabis | 15.7 | 21.2 | 10.2 | 4.8 | 2.1 | 0.6 | 5.7 |
Cocaine | 3.1 | 2.2 | 1.1 | 1.3 | 0.4 | - | 0.8 |
Crack | - | - | 0.5 | - | - | - | 0.1 |
Ecstasy | 6.3 | 2.7 | 2.7 | 0.4 | 0.8 | - | 1.2 |
Heroin | - | 0.5 | - | - | - | - | 0.1 |
Methadone | - | 0.5 | - | - | - | - | 0.1 |
LSD | - | - | - | - | - | - | - |
Magic mushrooms | - | 0.5 | 0.5 | - | - | - | 0.1 |
Temazepam | - | - | - | 0.4 | | 0.1 | 0.1 |
Valium | 4.7 | 0.5 | - | 0.9 | - | - | 0.5 |
Glues | - | - | - | - | - | - | - |
Pills | - | - | - | - | - | 0.1 | 0.1 |
Anabolic steroids | - | - | - | - | 0.4 | 0.3 | 0.2 |
Poppers | 3.1 | 1.6 | - | 0.4 | 0.4 | - | 0.5 |
Notes:
1. Fifty-one respondents who reported using the bogus drug were excluded from this analysis.
2. A dash '-' signifies that no respondents within that demographic group reported using that drug.
3. Source: 2003 SCS, unweighted n=1,717.
16-19, unweighted n, women=86
20-24, unweighted n, women=148
25-29, unweighted n, women=181
30-34, unweighted n, women=247
35-39, unweighted n, women=250
40-59, unweighted n, women=805.
« Previous | Contents | Next »